Company Filing History:
5 out of 113 
3 out of 1,381 
2 out of 2 Years Active: 2007-2015
Title: The Innovative Contributions of Randall K. Holmes in Immunology
Introduction: Randall K. Holmes, based in Golden, Colorado, is an accomplished inventor with a notable portfolio of six patents in the field of immunology. His work primarily focuses on the development of innovative immunogenic compositions, which have significant implications for enhancing immune responses against various pathogens.
Latest Patents: Holmes' latest patented inventions showcase his expertise in creating advanced immunogenic compositions. One of his notable inventions relates to an immunogenic composition composed of a chimeric molecule, which includes a conformationally stable adhesin fused to a bacterial toxin A subunit, such as cholera toxin A subunit or heat-labile toxin A subunit. This invention also encompasses an adhesin-toxin chimera noncovalently associated with a toxin B subunit of the same or a different species as the A subunit. Additionally, Holmes has developed mutant forms of cholera holotoxin that possess reduced toxicity compared to the wild-type version. These mutant cholera holotoxins serve as effective adjuvants in antigenic compositions, significantly enhancing immune responses in vertebrate hosts to selected antigens from various pathogens, cancer cells, and allergens.
Career Highlights: Randall K. Holmes has made significant strides in the field of immunology during his career, with pivotal roles at several esteemed institutions. He has worked for Wyeth Holdings Corporation and the University of Colorado, contributing to cutting-edge research and development in immunology.
Collaborations: Throughout his career, Holmes has collaborated with distinguished colleagues such as Michael G. Jobling and Bruce Arthur Green. These collaborations have facilitated advancements in his research, leading to innovative solutions in immunogenic composition development.
Conclusion: Randall K. Holmes exemplifies innovation in the field of immunology through his extensive patent portfolio and collaborative efforts. His contributions continue to advance our understanding and application of immunogenic technologies, impacting both therapeutic and preventive measures against infectious diseases and other health challenges.